Chinese
ReLIA cardiac assays were developed by the proprietary bilateral flow immunoassay technology to measure the concentration of cardiac biomarkers in blood samples.
ReLIA Assays for infectious diseases were developed by the proprietary bilateral flow immuno technology to quickly detect various anti-viral antibodies in human blood samples.
ReLIA Diagnostic Systems, Inc. has developed a low-cost, high-performance, portable immunoassay system for Point-of-Care (POC) that provides the sensitivity, precision, accuracy and reliability of expensive and complex central laboratory systems, with the . . .
loading...
